| Nome |
# |
|
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study, file e4233f16-d1c2-2860-e053-6605fe0a460a
|
63
|
|
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study, file e4233f17-291f-2860-e053-6605fe0a460a
|
48
|
|
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis, file e4233f17-e7c3-2860-e053-6605fe0a460a
|
31
|
|
Prognostic nutritional index in elderly patients hospitalized for acute heart failure, file e4233f17-a58f-2860-e053-6605fe0a460a
|
23
|
|
Gastrointestinal manifestations of SARS-CoV-2 infection in an Italian population of hospitalized patients, file e4233f19-66ef-2860-e053-6605fe0a460a
|
20
|
|
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis, file e4233f17-d75d-2860-e053-6605fe0a460a
|
18
|
|
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: A retrospective multicenter study, file e4233f17-747f-2860-e053-6605fe0a460a
|
17
|
|
Anamnestic frailty phenotype and adverse outcomes in patients treated with direct oral anticoagulants: Validation and comparative performance with frailty phenotype, file d969f9db-6bd3-4c79-be57-7029f04f40dd
|
15
|
|
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study, file e4233f18-83dd-2860-e053-6605fe0a460a
|
13
|
|
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism, file e4233f18-91f4-2860-e053-6605fe0a460a
|
13
|
|
Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study, file e4233f18-c8c3-2860-e053-6605fe0a460a
|
13
|
|
Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation, file e4233f18-87a6-2860-e053-6605fe0a460a
|
12
|
|
Effects of Obesity and Thrombophilia on the Risk of Abortion in Women Undergoing In Vitro Fertilization, file e4233f18-77c5-2860-e053-6605fe0a460a
|
10
|
|
Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone, file e4233f18-880a-2860-e053-6605fe0a460a
|
10
|
|
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy., file e4233f15-c98e-2860-e053-6605fe0a460a
|
9
|
|
SGLT2-inhibitors and euglycemic diabetic ketoacidosis in COVID-19 pandemic era: a case report, file 00b40035-8369-4a29-b8be-acb87d780777
|
8
|
|
null, file 095c1c34-c21a-4d75-b9f2-f012cb76b99b
|
8
|
|
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization, file e4233f17-0501-2860-e053-6605fe0a460a
|
8
|
|
Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study, file e4233f18-c81d-2860-e053-6605fe0a460a
|
8
|
|
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19, file e4233f18-153f-2860-e053-6605fe0a460a
|
7
|
|
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study, file e4233f16-051b-2860-e053-6605fe0a460a
|
6
|
|
null, file e4233f19-56ca-2860-e053-6605fe0a460a
|
6
|
|
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis, file e4233f17-04ff-2860-e053-6605fe0a460a
|
5
|
|
Morning Blood Pressure Surge, Dipping, and Risk of Coronary Events in Elderly Treated Hypertensive Patients, file e4233f15-9755-2860-e053-6605fe0a460a
|
4
|
|
Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients., file e4233f15-9802-2860-e053-6605fe0a460a
|
4
|
|
Evidence for oxidative and not reductive stress in the aged rabbit heart, file e4233f17-ae3e-2860-e053-6605fe0a460a
|
4
|
|
Smell and Taste in Severe CoViD-19: Self-Reported vs. Testing, file e4233f18-3e22-2860-e053-6605fe0a460a
|
4
|
|
Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism, file ff59e4b2-9336-4900-836d-9730ff71a76c
|
4
|
|
Anamnestic frailty phenotype and adverse outcomes in patients treated with direct oral anticoagulants: Validation and comparative performance with frailty phenotype, file 3cc57eee-974a-4646-8eac-b39a6c3c392e
|
3
|
|
Venous thromboembolism in pancreatic cancer patients: Time to consider routine thromboprophylaxis?, file 728de6db-4b93-4555-8aa0-779cb3b9955a
|
3
|
|
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy, file df920d25-96c3-4086-94e2-33b794f9634a
|
3
|
|
Glutathione-related enzyme activities and lipoperoxide levels in human internal mammary artery and ascending aorta. Relations with serum lipids, file e4233f14-f253-2860-e053-6605fe0a460a
|
3
|
|
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry, file e4233f17-9838-2860-e053-6605fe0a460a
|
3
|
|
Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients, file e4233f19-6dfa-2860-e053-6605fe0a460a
|
3
|
|
Safety and feasibility of diagnostic algorithm combining clinical probability, D-dimer and ultrasonography in suspected upper extremity deep vein thrombosis: a prospective management study., file e4233f15-1312-2860-e053-6605fe0a460a
|
2
|
|
Ambulatory Blood Pressure Parameters and Heart Failure With Reduced or Preserved Ejection Fraction in Elderly Treated Hypertensive Patients, file e4233f15-97f8-2860-e053-6605fe0a460a
|
2
|
|
Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study., file e4233f16-3b8e-2860-e053-6605fe0a460a
|
2
|
|
Reduced variability to aspirin antiplatelet effect by the coadministration of statins in high-risk patients for cardiovascular disease., file e4233f16-e13b-2860-e053-6605fe0a460a
|
2
|
|
Impaired glutathione-related antioxidant defenses in the arterial tissue of diabetic patients, file e4233f17-25f2-2860-e053-6605fe0a460a
|
2
|
|
Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients, file e4233f17-759d-2860-e053-6605fe0a460a
|
2
|
|
Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis, file e4233f17-e052-2860-e053-6605fe0a460a
|
2
|
|
Risk factors and current management of venous thromboembolism in patients with primary immune thrombocytopenic purpura, file e4233f18-7ce9-2860-e053-6605fe0a460a
|
2
|
|
Clinical history of cancer-associated splanchnic vein thrombosis, file e4233f18-96da-2860-e053-6605fe0a460a
|
2
|
|
Follow-up management of patients receiving direct oral anticoagulants, file e4233f18-b021-2860-e053-6605fe0a460a
|
2
|
|
Age- versus clinical pretest probability-adjusted D-dimer to rule out lower-extremity deep vein thrombosis in ambulatory patients with active cancer, file e9f6070c-d2a3-4a4a-bd99-aea91f01b418
|
2
|
|
Venous thromboembolism in pancreatic cancer patients: Time to consider routine thromboprophylaxis?, file a3996415-2250-47f5-9cef-3cb211d197ec
|
1
|
|
Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants, file cf7d4446-03e6-4793-bce9-2ad0f4927a22
|
1
|
|
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques., file e4233f14-edfe-2860-e053-6605fe0a460a
|
1
|
|
Antiproliferative effect of deferoxamine on vascular muscle cells in vitro and in vivo., file e4233f14-f248-2860-e053-6605fe0a460a
|
1
|
|
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy., file e4233f14-fc80-2860-e053-6605fe0a460a
|
1
|
|
Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism, file e4233f15-0898-2860-e053-6605fe0a460a
|
1
|
|
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score, file e4233f16-0906-2860-e053-6605fe0a460a
|
1
|
|
Safety and efficacy of low-dose fondaparinux (1.5mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The FONDAIR study, file e4233f16-7932-2860-e053-6605fe0a460a
|
1
|
|
Rivaroxaban or aspirin for extended treatment of venous thromboembolism, file e4233f17-7e40-2860-e053-6605fe0a460a
|
1
|
|
Oral apixaban for the treatment of acute venous thromboembolism, file e4233f17-8184-2860-e053-6605fe0a460a
|
1
|
|
Extended venous thromboprophylaxis in patients hospitalized for acute ischemic stroke: A systematic review and meta-analysis, file e4233f18-9e59-2860-e053-6605fe0a460a
|
1
|
|
Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19, file e4233f18-a31f-2860-e053-6605fe0a460a
|
1
|
|
Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis, file e4233f18-daad-2860-e053-6605fe0a460a
|
1
|
|
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis, file e4233f19-086a-2860-e053-6605fe0a460a
|
1
|
|
Age- versus clinical pretest probability-adjusted D-dimer to rule out lower-extremity deep vein thrombosis in ambulatory patients with active cancer, file fb4260de-f6c0-4a66-929d-4c065565021a
|
1
|
| Totale |
446 |